Abiomed Inc (ABMD)

265.00 -0.64  -0.24% NASDAQ Jul 9, 16:58 Delayed 2m USD

Abiomed Profit Margin (Quarterly):

15.39% for March 31, 2020
View 4,000+ financial data types
Browse...
View Full Chart

Profit Margin (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Profit Margin (Quarterly) Data

View and export this data going back to 1986. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
March 31, 2020 15.39%
Dec. 31, 2019 31.24%
Sept. 30, 2019 6.38%
June 30, 2019 42.82%
March 31, 2019 35.72%
Dec. 31, 2018 22.37%
Sept. 30, 2018 27.58%
June 30, 2018 50.03%
March 31, 2018 21.12%
Dec. 31, 2017 8.73%
Sept. 30, 2017 18.45%
June 30, 2017 28.21%
March 31, 2017 11.95%
Dec. 31, 2016 13.46%
Sept. 30, 2016 8.62%
June 30, 2016 12.53%
March 31, 2016 11.71%
Dec. 31, 2015 12.30%
Sept. 30, 2015 10.13%
June 30, 2015 12.06%
March 31, 2015
Dec. 31, 2014 20.46%
Sept. 30, 2014 7.39%
June 30, 2014 -3.50%
March 31, 2014 7.18%
   
Dec. 31, 2013 9.51%
Sept. 30, 2013 2.39%
June 30, 2013 -4.04%
March 31, 2013 8.57%
Dec. 31, 2012 7.02%
Sept. 30, 2012 14.62%
June 30, 2012 8.04%
March 31, 2012 6.87%
Dec. 31, 2011 9.07%
Sept. 30, 2011 2.04%
June 30, 2011 -16.79%
March 31, 2011 -6.21%
Dec. 31, 2010 -2.94%
Sept. 30, 2010 -13.69%
June 30, 2010 -27.18%
March 31, 2010 4.24%
Dec. 31, 2009 -20.02%
Sept. 30, 2009 -38.33%
June 30, 2009 -38.97%
March 31, 2009 -43.17%
Dec. 31, 2008 -44.58%
Sept. 30, 2008 -31.65%
June 30, 2008 -55.72%
March 31, 2008 -85.52%
Dec. 31, 2007 -51.83%

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Benchmarks

Benchmarks
Baxter International Inc 11.81%
Biogen Inc 39.59%
Gilead Sciences Inc 27.96%

Profit Margin (Quarterly) Range, Past 5 Years

Minimum 6.38% Sep 2019
Maximum 50.03% Jun 2018
Average 20.46%
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.